Skip to main content
Journal cover image

Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial

Publication ,  Conference
Held, C; Hylek, EB; Alexander, JH; Hanna, M; Lopes, RD; Wojdyla, D; Granger, CB; Wallentin, L
Published in: EUROPEAN HEART JOURNAL
August 1, 2013

Duke Scholars

Published In

EUROPEAN HEART JOURNAL

EISSN

1522-9645

ISSN

0195-668X

Publication Date

August 1, 2013

Volume

34

Start / End Page

99 / 99

Location

Amsterdam, NETHERLANDS

Publisher

OXFORD UNIV PRESS

Conference Name

Congress of the European-Society-of-Cardiology (ESC)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Held, C., Hylek, E. B., Alexander, J. H., Hanna, M., Lopes, R. D., Wojdyla, D., … Wallentin, L. (2013). Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial. In EUROPEAN HEART JOURNAL (Vol. 34, pp. 99–99). Amsterdam, NETHERLANDS: OXFORD UNIV PRESS.
Held, C., E. B. Hylek, J. H. Alexander, M. Hanna, R. D. Lopes, D. Wojdyla, C. B. Granger, and L. Wallentin. “Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial.” In EUROPEAN HEART JOURNAL, 34:99–99. OXFORD UNIV PRESS, 2013.
Held C, Hylek EB, Alexander JH, Hanna M, Lopes RD, Wojdyla D, et al. Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2013. p. 99–99.
Held, C., et al. “Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial.” EUROPEAN HEART JOURNAL, vol. 34, OXFORD UNIV PRESS, 2013, pp. 99–99.
Held C, Hylek EB, Alexander JH, Hanna M, Lopes RD, Wojdyla D, Granger CB, Wallentin L. Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2013. p. 99–99.
Journal cover image

Published In

EUROPEAN HEART JOURNAL

EISSN

1522-9645

ISSN

0195-668X

Publication Date

August 1, 2013

Volume

34

Start / End Page

99 / 99

Location

Amsterdam, NETHERLANDS

Publisher

OXFORD UNIV PRESS

Conference Name

Congress of the European-Society-of-Cardiology (ESC)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology